Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
1-Minute Consult

Should we monitor troponin up to peak value when evaluating for acute coronary syndrome?

Nolan Anderson, MD, Samuel T. Ives, MD, Michelle D. Carlson, MD and Fred Apple, PhD, DABCC
Cleveland Clinic Journal of Medicine August 2020, 87 (8) 480-482; DOI: https://doi.org/10.3949/ccjm.87a.18125
Nolan Anderson
Pediatric Residency Program, University of Washington, Seattle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel T. Ives
Division of General Internal Medicine, Hennepin Healthcare, Minneapolis, MN; Assistant Professor of Medicine, Department of Medicine, University of Minnesota, Minneapolis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: samuel.ives@hcmed.org
Michelle D. Carlson
Division of Cardiology, Hennepin Healthcare, Minneapolis, MN; Assistant Professor of Medicine, Department of Medicine, University of Minnesota, Minneapolis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fred Apple
Co-Medical Director, Clinical & Forensic Toxicology Laboratory, Hennepin Healthcare/Hennepin County Medical Center; Principal Investigator, Cardiac Biomarkers Trials Laboratory, Hennepin Healthcare Research Institute; Professor, Laboratory Medicine & Pathology, University of Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 87 no. 8 480-482
DOI 
https://doi.org/10.3949/ccjm.87a.18125
PubMed 
32737047

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online July 31, 2020.

Copyright & Usage 
Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Nolan Anderson, MD
  1. Pediatric Residency Program, University of Washington, Seattle
  1. Samuel T. Ives, MD⇑
  1. Division of General Internal Medicine, Hennepin Healthcare, Minneapolis, MN; Assistant Professor of Medicine, Department of Medicine, University of Minnesota, Minneapolis
  1. Address:
    Samuel T. Ives, MD, Department of Medicine, University of Minnesota, 516 Delaware Street SE, Minneapolis, MN 55414; samuel.ives{at}hcmed.org
  1. Michelle D. Carlson, MD
  1. Division of Cardiology, Hennepin Healthcare, Minneapolis, MN; Assistant Professor of Medicine, Department of Medicine, University of Minnesota, Minneapolis
  1. Fred Apple, PhD, DABCC
  1. Co-Medical Director, Clinical & Forensic Toxicology Laboratory, Hennepin Healthcare/Hennepin County Medical Center; Principal Investigator, Cardiac Biomarkers Trials Laboratory, Hennepin Healthcare Research Institute; Professor, Laboratory Medicine & Pathology, University of Minnesota

Cited By...

  • 1 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 87 (8)
Cleveland Clinic Journal of Medicine
Vol. 87, Issue 8
1 Aug 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Should we monitor troponin up to peak value when evaluating for acute coronary syndrome?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Should we monitor troponin up to peak value when evaluating for acute coronary syndrome?
Nolan Anderson, Samuel T. Ives, Michelle D. Carlson, Fred Apple
Cleveland Clinic Journal of Medicine Aug 2020, 87 (8) 480-482; DOI: 10.3949/ccjm.87a.18125

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Should we monitor troponin up to peak value when evaluating for acute coronary syndrome?
Nolan Anderson, Samuel T. Ives, Michelle D. Carlson, Fred Apple
Cleveland Clinic Journal of Medicine Aug 2020, 87 (8) 480-482; DOI: 10.3949/ccjm.87a.18125
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • DEFINITIONS
    • DISTINGUISHING THE CAUSE OF TROPONIN ELEVATION
    • DOES TROPONIN PREDICT ADVERSE EVENTS?
    • IF SYMPTOMS RECUR
    • TESTING INCREASES COSTS
    • NEW TESTS DO NOT CHANGE THE MESSAGE
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

  • Cardiac troponin testing: Goodbye, ‘troponinemia’
  • PubMed
  • Google Scholar

Cited By...

  • Cardiac troponin testing: Goodbye, 'troponinemia
  • Google Scholar

More in this TOC Section

  • What are the treatment options for myasthenia gravis if first-line agents fail?
  • Which patients hospitalized with alcohol withdrawal syndrome should receive high-dose parenteral thiamine?
  • What are my obligations to my incarcerated patient?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Emergency Medicine
  • Cardiology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire